Allspring Global Investments
MDGL icon

Allspring Global Investments’s Madrigal Pharmaceuticals MDGL Stock Holding History

Allspring Global Investments’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.8M Buy
67,668
+66,470
+5,548% +$34M 0.05% 413
2026
Q1 		$635K Buy
1,198
+567
+90% +$271K ﹤0.01% 1327
2025
Q4 		$375K Buy
+631
New +$322K ﹤0.01% 1456
2024
Q4 		– Sell
-25
Closed -$5.3K – 2144
2024
Q3 		$5.3K Sell
25
-352
-93% -$90.1K ﹤0.01% 2170
2024
Q2 		$106K Sell
377
-4
-1% -$952 ﹤0.01% 1842
2024
Q1 		$102K Buy
+381
New +$89.8K ﹤0.01% 1843
2023
Q4 		– Sell
-314
Closed -$45.9K – 2528
2023
Q3 		$45.9K Sell
314
-6,554
-95% -$1.23M ﹤0.01% 2300
2023
Q2 		$1.59M Buy
6,868
+6,180
+898% +$1.67M ﹤0.01% 1304
2023
Q1 		$167K Sell
688
-348
-34% -$94.8K ﹤0.01% 1875
2022
Q4 		$301K Sell
1,036
-154
-13% -$15.1K ﹤0.01% 1733
2022
Q3 		$77K Buy
1,190
+352
+42% +$24.5K ﹤0.01% 2180
2022
Q2 		$59K Sell
838
-4,280
-84% -$315K ﹤0.01% 2209
2022
Q1 		$502K Buy
5,118
+194
+4% +$16.4K ﹤0.01% 2216
2021
Q4 		$417K Buy
+4,924
New +$405K ﹤0.01% 2372

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Allspring Global Investments's MDGL Position: Q2 2026 in Review

Allspring Global Investments increased its Madrigal Pharmaceuticals (MDGL) stake by 5,548% in Q2 2026, buying an estimated $34M and bringing the position to 67,668 shares worth $34.8M. The position accounts for 0.05% of the portfolio, ranked #413.

Allspring Global Investments first reported a position in MDGL in Q4 2021 and has held it in 14 quarters since. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Allspring Global Investments held 67,668 shares of Madrigal Pharmaceuticals worth $34.8M as of Q2 2026.
  • Allspring Global Investments bought 66,470 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $34M.
  • Madrigal Pharmaceuticals made up 0.05% of Allspring Global Investments's portfolio in Q2 2026, its #413 holding.
  • Allspring Global Investments first reported a position in Madrigal Pharmaceuticals in Q4 2021 and has held it in 14 quarters since.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.